URL: http://www.alzprotect.com/en/
Proper Citation: AlzProtect (RRID:SCR_000492)
Description: Commercial organization that develops drug candidates in the field of neurodegenerative diseases and particularly Alzheimer's. Their main objective is the development of a drug against Alzheimer's disease from molecules patented by Inserm and the University of Lille II.
Abbreviations: AlzProtect
Synonyms: Alz Protect, SAS AlzProtect, Alzprotect SAS, AlzProtect - Therapeutic Solutions for Neurodegeneration
Resource Type: commercial organization
Keywords: late adult human, drug, molecule, neurodegeneration, medicine, drug development
Expand Allis related to |
We found {{ ctrl2.mentions.total_count }} mentions in open access literature.
We have not found any literature mentions for this resource.
We are searching literature mentions for this resource.
Most recent articles:
{{ mention._source.dc.creators[0].familyName }} {{ mention._source.dc.creators[0].initials }}, et al. ({{ mention._source.dc.publicationYear }}) {{ mention._source.dc.title }} {{ mention._source.dc.publishers[0].name }}, {{ mention._source.dc.publishers[0].volume }}({{ mention._source.dc.publishers[0].issue }}), {{ mention._source.dc.publishers[0].pagination }}. (PMID:{{ mention._id.replace('PMID:', '') }})
Check
for all resource mentions.
A list of researchers who have used the resource and an author search tool
Find mentions based on location
{{ ctrl2.mentions.errors.location }}
A list of researchers who have used the resource and an author search tool. This is available for resources that have literature mentions.
No rating or validation information has been found for AlzProtect.
No alerts have been found for AlzProtect.
Source: SciCrunch Registry
